Receptor group

5-HT2 receptors

3 related receptors and the ligands measured at several of them.

Binding affinity (Kᵢ)

30 ligands measured at two or more members, human values in nM, strongest first. Select a value for its assay and source.

View
Ligand5-HT2A receptor5-HT2B receptor5-HT2C receptor
DOB
DOI
2C-B
LSD
Bufotenin
Psilocin
ETH-LAD
2C-E
4-HO-MET
AL-LAD
DOM
5-MeO-DMT
5-MeO-MiPT
MDA
DMT
Psilocybin
MDMA
2C-Inot measured
2C-Pnot measured
ALD-52not measured
2C-Cnot measured
2C-Dnot measured
6-APBnot measured
Mescaline
5-APBnot measured
4-FMAnot measured
Mephedronenot measured
Methylone
Ephedrinenot measured
4-FAnot measured
DOB at 5-HT2A: Kᵢ 0.60 nM, other reports differ, Nelson et al. 1999DOB at 5-HT2B: Kᵢ 27 nM, other reports differ, Nelson et al. 1999DOB at 5-HT2C: Kᵢ 1.3 nM, other reports differ, Nelson et al. 1999DOI at 5-HT2A: Kᵢ 0.70 nM, other reports differ, Nelson et al. 1999DOI at 5-HT2B: Kᵢ 20 nM, other reports differ, Nelson et al. 1999DOI at 5-HT2C: Kᵢ 2.4 nM, other reports differ, Nelson et al. 19992C-B at 5-HT2A: Kᵢ 0.88 nM, other reports differ, McLean et al. 20062C-B at 5-HT2B: Kᵢ 14 nM, Ray 20102C-B at 5-HT2C: Kᵢ 47 nM, Rickli et al. 2015LSD at 5-HT2A: Kᵢ 15 nM, other reports differ, Halberstadt et al. 2020LSD at 5-HT2B: Kᵢ 5.5 nM, other reports differ, Jain et al. 2025LSD at 5-HT2C: Kᵢ 45 nM, other reports differ, Halberstadt et al. 2020Bufotenin at 5-HT2A: Kᵢ 162 nM, Almaula et al. 1996Bufotenin at 5-HT2B: Kᵢ 6.2 nM, other reports differ, Jain et al. 2025Bufotenin at 5-HT2C: Kᵢ 210 nM, Jain et al. 2025Psilocin at 5-HT2A: Kᵢ 200 nM, other reports differ, Jain et al. 2025Psilocin at 5-HT2B: Kᵢ 8.0 nM, other reports differ, Glatfelter et al. 2022Psilocin at 5-HT2C: Kᵢ 94 nM, Rickli et al. 2016ETH-LAD at 5-HT2A: Kᵢ 9.3 nM, Jain et al. 2025ETH-LAD at 5-HT2B: Kᵢ 18 nM, Jain et al. 2025ETH-LAD at 5-HT2C: Kᵢ 56 nM, Jain et al. 20252C-E at 5-HT2A: Kᵢ 11 nM, other reports differ, Rickli et al. 20152C-E at 5-HT2B: Kᵢ 25 nM, Ray 20102C-E at 5-HT2C: Kᵢ 100 nM, other reports differ, Rickli et al. 20154-HO-MET at 5-HT2A: Kᵢ 46 nM, Kozell et al. 20234-HO-MET at 5-HT2B: Kᵢ 12 nM, Glatfelter et al. 20234-HO-MET at 5-HT2C: Kᵢ 153 nM, Kozell et al. 2023AL-LAD at 5-HT2A: Kᵢ 17 nM, Jain et al. 2025AL-LAD at 5-HT2B: Kᵢ 14 nM, Jain et al. 2025AL-LAD at 5-HT2C: Kᵢ 68 nM, Jain et al. 2025DOM at 5-HT2A: Kᵢ 18 nM, other reports differ, Eshleman et al. 2018DOM at 5-HT2B: Kᵢ 41 nM, other reports differ, Eshleman et al. 2018DOM at 5-HT2C: Kᵢ 19 nM, other reports differ, Eshleman et al. 20185-MeO-DMT at 5-HT2A: Kᵢ 105 nM, other reports differ, Puigseslloses et al. 20245-MeO-DMT at 5-HT2B: Kᵢ 36 nM, other reports differ, Halberstadt et al. 20125-MeO-DMT at 5-HT2C: Kᵢ 266 nM, Glatfelter et al. 20245-MeO-MiPT at 5-HT2A: Kᵢ 113 nM, other reports differ, Kozell et al. 20235-MeO-MiPT at 5-HT2B: Kᵢ 53 nM, Glatfelter et al. 20245-MeO-MiPT at 5-HT2C: Kᵢ 790 nM, Kozell et al. 2023MDA at 5-HT2A: Kᵢ 3300 nM, Rickli et al. 2015MDA at 5-HT2B: Kᵢ 91 nM, Ray 2010MDA at 5-HT2C: Kᵢ 3000 nM, Rickli et al. 2015DMT at 5-HT2A: Kᵢ 347 nM, other reports differ, Kozell et al. 2023DMT at 5-HT2B: Kᵢ 110 nM, Jain et al. 2025DMT at 5-HT2C: Kᵢ 234 nM, other reports differ, Kozell et al. 2023Psilocybin at 5-HT2A: Kᵢ 850 nM, Jain et al. 2025Psilocybin at 5-HT2B: Kᵢ 259 nM, Glatfelter et al. 2022Psilocybin at 5-HT2C: Kᵢ 808 nM, other reports differ, Glatfelter et al. 2022MDMA at 5-HT2A: Kᵢ 8300 nM, Eshleman et al. 2013MDMA at 5-HT2B: Kᵢ 270 nM, Jain et al. 2025MDMA at 5-HT2C: Kᵢ 1500 nM, other reports differ, Jain et al. 20252C-I at 5-HT2A: Kᵢ 3.5 nM, Rickli et al. 20152C-I at 5-HT2C: Kᵢ 40 nM, other reports differ, Rickli et al. 20152C-P at 5-HT2A: Kᵢ 8.1 nM, Rickli et al. 20152C-P at 5-HT2C: Kᵢ 40 nM, Rickli et al. 2015ALD-52 at 5-HT2A: Kᵢ 174 nM, Halberstadt et al. 2020ALD-52 at 5-HT2C: Kᵢ 10 nM, Halberstadt et al. 20202C-C at 5-HT2A: Kᵢ 13 nM, Rickli et al. 20152C-C at 5-HT2C: Kᵢ 90 nM, other reports differ, Rickli et al. 20152C-D at 5-HT2A: Kᵢ 32 nM, Rickli et al. 20152C-D at 5-HT2C: Kᵢ 150 nM, other reports differ, Rickli et al. 20156-APB at 5-HT2A: Kᵢ 970 nM, Rickli et al. 20156-APB at 5-HT2C: Kᵢ 270 nM, Rickli et al. 2015Mescaline at 5-HT2A: Kᵢ 6300 nM, other reports differ, Rickli et al. 2015Mescaline at 5-HT2B: Kᵢ 400 nM, Jain et al. 2025Mescaline at 5-HT2C: Kᵢ of 10 µM or weaker5-APB at 5-HT2A: Kᵢ 840 nM, Rickli et al. 20155-APB at 5-HT2C: Kᵢ 880 nM, Rickli et al. 20154-FMA at 5-HT2A: Kᵢ 3800 nM, Rickli et al. 20154-FMA at 5-HT2C: Kᵢ 5500 nM, Rickli et al. 2015Mephedrone at 5-HT2A: Kᵢ 9000 nM, other reports differ, Eshleman et al. 2013Mephedrone at 5-HT2C: Kᵢ 9100 nM, Eshleman et al. 2013Methylone at 5-HT2B: Kᵢ 1800 nM, Jain et al. 2025Methylone at 5-HT2A: Kᵢ of 10 µM or weakerMethylone at 5-HT2C: Kᵢ of 10 µM or weakerEphedrine at 5-HT2C: Kᵢ 3300 nM, Rickli et al. 2015Ephedrine at 5-HT2A: Kᵢ of 10 µM or weaker4-FA at 5-HT2C: Kᵢ 7800 nM, Rickli et al. 20154-FA at 5-HT2A: Kᵢ of 10 µM or weaker5-HT2A receptor5-HT2A5-HT2B receptor5-HT2B5-HT2C receptor5-HT2CDOB, Kᵢ: 5-HT2A 0.60 nM, 5-HT2B 27 nM, 5-HT2C 1.3 nMDOBDOI, Kᵢ: 5-HT2A 0.70 nM, 5-HT2B 20 nM, 5-HT2C 2.4 nMDOI2C-B, Kᵢ: 5-HT2A 0.88 nM, 5-HT2B 14 nM, 5-HT2C 47 nM2C-BLSD, Kᵢ: 5-HT2A 15 nM, 5-HT2B 5.5 nM, 5-HT2C 45 nMLSDBufotenin, Kᵢ: 5-HT2A 162 nM, 5-HT2B 6.2 nM, 5-HT2C 210 nMBufoteninPsilocin, Kᵢ: 5-HT2A 200 nM, 5-HT2B 8.0 nM, 5-HT2C 94 nMPsilocinETH-LAD, Kᵢ: 5-HT2A 9.3 nM, 5-HT2B 18 nM, 5-HT2C 56 nMETH-LAD2C-E, Kᵢ: 5-HT2A 11 nM, 5-HT2B 25 nM, 5-HT2C 100 nM2C-E4-HO-MET, Kᵢ: 5-HT2A 46 nM, 5-HT2B 12 nM, 5-HT2C 153 nM4-HO-METAL-LAD, Kᵢ: 5-HT2A 17 nM, 5-HT2B 14 nM, 5-HT2C 68 nMAL-LADDOM, Kᵢ: 5-HT2A 18 nM, 5-HT2B 41 nM, 5-HT2C 19 nMDOM5-MeO-DMT, Kᵢ: 5-HT2A 105 nM, 5-HT2B 36 nM, 5-HT2C 266 nM5-MeO-DMT5-MeO-MiPT, Kᵢ: 5-HT2A 113 nM, 5-HT2B 53 nM, 5-HT2C 790 nM5-MeO-MiPTMDA, Kᵢ: 5-HT2A 3300 nM, 5-HT2B 91 nM, 5-HT2C 3000 nMMDADMT, Kᵢ: 5-HT2A 347 nM, 5-HT2B 110 nM, 5-HT2C 234 nMDMTPsilocybin, Kᵢ: 5-HT2A 850 nM, 5-HT2B 259 nM, 5-HT2C 808 nMPsilocybinMDMA, Kᵢ: 5-HT2A 8300 nM, 5-HT2B 270 nM, 5-HT2C 1500 nMMDMA2C-I, Kᵢ: 5-HT2A 3.5 nM, 5-HT2C 40 nM2C-I2C-P, Kᵢ: 5-HT2A 8.1 nM, 5-HT2C 40 nM2C-PALD-52, Kᵢ: 5-HT2A 174 nM, 5-HT2C 10 nMALD-522C-C, Kᵢ: 5-HT2A 13 nM, 5-HT2C 90 nM2C-C2C-D, Kᵢ: 5-HT2A 32 nM, 5-HT2C 150 nM2C-D6-APB, Kᵢ: 5-HT2A 970 nM, 5-HT2C 270 nM6-APBMescaline, Kᵢ: 5-HT2A 6300 nM, 5-HT2B 400 nM, 5-HT2C 10 µM or weakerMescaline5-APB, Kᵢ: 5-HT2A 840 nM, 5-HT2C 880 nM5-APB4-FMA, Kᵢ: 5-HT2A 3800 nM, 5-HT2C 5500 nM4-FMAMephedrone, Kᵢ: 5-HT2A 9000 nM, 5-HT2C 9100 nMMephedroneMethylone, Kᵢ: 5-HT2A 10 µM or weaker, 5-HT2B 1800 nM, 5-HT2C 10 µM or weakerMethyloneEphedrine, Kᵢ: 5-HT2A 10 µM or weaker, 5-HT2C 3300 nMEphedrine4-FA, Kᵢ: 5-HT2A 10 µM or weaker, 5-HT2C 7800 nM4-FA
stronger weaker other reports differ 10 µM or weaker (when shown)no line not measured or filtered out, not “inactive”

Lines connect each ligand to the members it has a displayed human Kᵢ at. The thicker and darker the line, the stronger the value. A ligand sits close to the members it binds most strongly and between those it binds about equally, so its position is only approximate. Select a ligand or a member to follow its lines, or a line to see its assay and source. The table view lists the same values.

Functional potency (EC₅₀)

24 ligands measured at two or more members, human values in nM, strongest first. Select a value for its assay and source.

View
Ligand5-HT2A receptor5-HT2B receptor5-HT2C receptor
LSD
DOB
DOI
Psilocin
Bufotenin
2C-I
2C-E
AL-LAD
5-MeO-DMT
ETH-LAD
DOM
5-MeO-MiPT
2C-C
2C-D
DMT
Psilocybin
MDMA
4-HO-MET
2C-Bnot measured
2C-Pnot measured
6-APBnot measured
5-APBnot measured
MDAnot measured
Mescaline
ALD-52not measurednot measured
LSD at 5-HT2A: EC₅₀ 0.71 nM, other reports differ, Eshleman et al. 2018LSD at 5-HT2B: EC₅₀ 3.1 nM, other reports differ, Eshleman et al. 2018LSD at 5-HT2C: EC₅₀ 1.7 nM, other reports differ, Eshleman et al. 2018DOB at 5-HT2A: EC₅₀ 1.5 nM, other reports differ, Porter et al. 1999DOB at 5-HT2B: EC₅₀ 2.9 nM, Porter et al. 1999DOB at 5-HT2C: EC₅₀ 7.8 nM, other reports differ, Porter et al. 1999DOI at 5-HT2A: EC₅₀ 1.8 nM, other reports differ, Elmore et al. 2018DOI at 5-HT2B: EC₅₀ 6.9 nM, other reports differ, Jain et al. 2025DOI at 5-HT2C: EC₅₀ 7.9 nM, other reports differ, Porter et al. 1999Psilocin at 5-HT2A: EC₅₀ 2.4 nM, other reports differ, Klein et al. 2020Psilocin at 5-HT2B: EC₅₀ 8.0 nM, other reports differ, Glatfelter et al. 2022Psilocin at 5-HT2C: EC₅₀ 34 nM, other reports differ, Glatfelter et al. 2022Bufotenin at 5-HT2A: EC₅₀ 3.5 nM, other reports differ, Blough et al. 2014Bufotenin at 5-HT2B: EC₅₀ 6.2 nM, Jain et al. 2025Bufotenin at 5-HT2C: EC₅₀ 5.2 nM, Jain et al. 20252C-I at 5-HT2A: EC₅₀ 5.9 nM, other reports differ, Pottie et al. 20202C-I at 5-HT2B: EC₅₀ 150 nM, Rickli et al. 20152C-I at 5-HT2C: EC₅₀ 47 nM, other reports differ, Elmore et al. 20182C-E at 5-HT2A: EC₅₀ 6.9 nM, other reports differ, Pottie et al. 20202C-E at 5-HT2B: EC₅₀ 190 nM, Rickli et al. 20152C-E at 5-HT2C: EC₅₀ 18 nM, other reports differ, Eshleman et al. 2014AL-LAD at 5-HT2A: EC₅₀ 8.3 nM, Jain et al. 2025AL-LAD at 5-HT2B: EC₅₀ 100 nM, Jain et al. 2025AL-LAD at 5-HT2C: EC₅₀ 37 nM, Jain et al. 20255-MeO-DMT at 5-HT2A: EC₅₀ 8.9 nM, other reports differ, Glatfelter et al. 20245-MeO-DMT at 5-HT2B: EC₅₀ 11 nM, other reports differ, Glatfelter et al. 20245-MeO-DMT at 5-HT2C: EC₅₀ 23 nM, other reports differ, Jain et al. 2025ETH-LAD at 5-HT2A: EC₅₀ 9.3 nM, Jain et al. 2025ETH-LAD at 5-HT2B: EC₅₀ 58 nM, Jain et al. 2025ETH-LAD at 5-HT2C: EC₅₀ 83 nM, Jain et al. 2025DOM at 5-HT2A: EC₅₀ 40 nM, other reports differ, Eshleman et al. 2018DOM at 5-HT2B: EC₅₀ 145 nM, other reports differ, Eshleman et al. 2018DOM at 5-HT2C: EC₅₀ 13 nM, other reports differ, Jain et al. 20255-MeO-MiPT at 5-HT2A: EC₅₀ 17 nM, other reports differ, Glatfelter et al. 20245-MeO-MiPT at 5-HT2B: EC₅₀ 50 nM, other reports differ, Glatfelter et al. 20245-MeO-MiPT at 5-HT2C: EC₅₀ 179 nM, other reports differ, Kozell et al. 20232C-C at 5-HT2A: EC₅₀ 19 nM, other reports differ, Pottie et al. 20202C-C at 5-HT2B: EC₅₀ 280 nM, Rickli et al. 20152C-C at 5-HT2C: EC₅₀ 78 nM, other reports differ, Elmore et al. 20182C-D at 5-HT2A: EC₅₀ 44 nM, other reports differ, Pottie et al. 20202C-D at 5-HT2B: EC₅₀ 230 nM, Rickli et al. 20152C-D at 5-HT2C: EC₅₀ 71 nM, Eshleman et al. 2014DMT at 5-HT2A: EC₅₀ 527 nM, other reports differ, Kozell et al. 2023DMT at 5-HT2B: EC₅₀ 3400 nM, other reports differ, Rickli et al. 2016DMT at 5-HT2C: EC₅₀ 104 nM, Kozell et al. 2023Psilocybin at 5-HT2A: EC₅₀ 1242 nM, other reports differ, Glatfelter et al. 2022Psilocybin at 5-HT2B: EC₅₀ 612 nM, Glatfelter et al. 2022Psilocybin at 5-HT2C: EC₅₀ 3741 nM, Glatfelter et al. 2022MDMA at 5-HT2A: EC₅₀ 5200 nM, Jain et al. 2025MDMA at 5-HT2B: EC₅₀ 620 nM, Jain et al. 2025MDMA at 5-HT2C: EC₅₀ 2500 nM, Jain et al. 20254-HO-MET at 5-HT2A: EC₅₀ 4.0 nM, other reports differ, Klein et al. 20204-HO-MET at 5-HT2C: EC₅₀ 35 nM, Kozell et al. 20234-HO-MET at 5-HT2B: EC₅₀ of 10 µM or weaker2C-B at 5-HT2A: EC₅₀ 9.0 nM, other reports differ, Pottie et al. 20202C-B at 5-HT2B: EC₅₀ 130 nM, Rickli et al. 20152C-P at 5-HT2A: EC₅₀ 90 nM, Rickli et al. 20152C-P at 5-HT2B: EC₅₀ 130 nM, Rickli et al. 20156-APB at 5-HT2A: EC₅₀ 5900 nM, Rickli et al. 20156-APB at 5-HT2B: EC₅₀ 140 nM, Rickli et al. 20155-APB at 5-HT2A: EC₅₀ 6300 nM, Rickli et al. 20155-APB at 5-HT2B: EC₅₀ 280 nM, Rickli et al. 2015MDA at 5-HT2A: EC₅₀ 630 nM, Rickli et al. 2015MDA at 5-HT2B: EC₅₀ 850 nM, Rickli et al. 2015Mescaline at 5-HT2B: EC₅₀ 500 nM, Jain et al. 2025Mescaline at 5-HT2A: EC₅₀ of 10 µM or weakerMescaline at 5-HT2C: EC₅₀ of 10 µM or weakerALD-52 at 5-HT2A: EC₅₀ 38 nM, Halberstadt et al. 20205-HT2A receptor5-HT2A5-HT2B receptor5-HT2B5-HT2C receptor5-HT2CLSD, EC₅₀: 5-HT2A 0.71 nM, 5-HT2B 3.1 nM, 5-HT2C 1.7 nMLSDDOB, EC₅₀: 5-HT2A 1.5 nM, 5-HT2B 2.9 nM, 5-HT2C 7.8 nMDOBDOI, EC₅₀: 5-HT2A 1.8 nM, 5-HT2B 6.9 nM, 5-HT2C 7.9 nMDOIPsilocin, EC₅₀: 5-HT2A 2.4 nM, 5-HT2B 8.0 nM, 5-HT2C 34 nMPsilocinBufotenin, EC₅₀: 5-HT2A 3.5 nM, 5-HT2B 6.2 nM, 5-HT2C 5.2 nMBufotenin2C-I, EC₅₀: 5-HT2A 5.9 nM, 5-HT2B 150 nM, 5-HT2C 47 nM2C-I2C-E, EC₅₀: 5-HT2A 6.9 nM, 5-HT2B 190 nM, 5-HT2C 18 nM2C-EAL-LAD, EC₅₀: 5-HT2A 8.3 nM, 5-HT2B 100 nM, 5-HT2C 37 nMAL-LAD5-MeO-DMT, EC₅₀: 5-HT2A 8.9 nM, 5-HT2B 11 nM, 5-HT2C 23 nM5-MeO-DMTETH-LAD, EC₅₀: 5-HT2A 9.3 nM, 5-HT2B 58 nM, 5-HT2C 83 nMETH-LADDOM, EC₅₀: 5-HT2A 40 nM, 5-HT2B 145 nM, 5-HT2C 13 nMDOM5-MeO-MiPT, EC₅₀: 5-HT2A 17 nM, 5-HT2B 50 nM, 5-HT2C 179 nM5-MeO-MiPT2C-C, EC₅₀: 5-HT2A 19 nM, 5-HT2B 280 nM, 5-HT2C 78 nM2C-C2C-D, EC₅₀: 5-HT2A 44 nM, 5-HT2B 230 nM, 5-HT2C 71 nM2C-DDMT, EC₅₀: 5-HT2A 527 nM, 5-HT2B 3400 nM, 5-HT2C 104 nMDMTPsilocybin, EC₅₀: 5-HT2A 1242 nM, 5-HT2B 612 nM, 5-HT2C 3741 nMPsilocybinMDMA, EC₅₀: 5-HT2A 5200 nM, 5-HT2B 620 nM, 5-HT2C 2500 nMMDMA4-HO-MET, EC₅₀: 5-HT2A 4.0 nM, 5-HT2B 10 µM or weaker, 5-HT2C 35 nM4-HO-MET2C-B, EC₅₀: 5-HT2A 9.0 nM, 5-HT2B 130 nM2C-B2C-P, EC₅₀: 5-HT2A 90 nM, 5-HT2B 130 nM2C-P6-APB, EC₅₀: 5-HT2A 5900 nM, 5-HT2B 140 nM6-APB5-APB, EC₅₀: 5-HT2A 6300 nM, 5-HT2B 280 nM5-APBMDA, EC₅₀: 5-HT2A 630 nM, 5-HT2B 850 nMMDAMescaline, EC₅₀: 5-HT2A 10 µM or weaker, 5-HT2B 500 nM, 5-HT2C 10 µM or weakerMescalineALD-52, EC₅₀: 5-HT2A 38 nMALD-52
stronger weaker other reports differ 10 µM or weaker (when shown)no line not measured or filtered out, not “inactive”

Lines connect each ligand to the members it has a displayed human EC₅₀ at. The thicker and darker the line, the stronger the value. A ligand sits close to the members it binds most strongly and between those it binds about equally, so its position is only approximate. Select a ligand or a member to follow its lines, or a line to see its assay and source. The table view lists the same values.

stronger weaker≥ 10 µM measured, 10 µM or weakerempty not measured* other reports differ† source not traced to the original

Human values only. A cell shows the value displayed on the compound page, from one assay. Values from different assays are not directly interchangeable, and a value does not establish clinical potency or safety.